5glh: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
== | ==Human endothelin receptor type-B in complex with ET-1== | ||
<StructureSection load='5glh' size='340' side='right' caption='[[5glh]], [[Resolution|resolution]] 2.80Å' scene=''> | <StructureSection load='5glh' size='340' side='right' caption='[[5glh]], [[Resolution|resolution]] 2.80Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| Line 9: | Line 9: | ||
== Function == | == Function == | ||
[[http://www.uniprot.org/uniprot/EDN1_HUMAN EDN1_HUMAN]] Endothelins are endothelium-derived vasoconstrictor peptides. | [[http://www.uniprot.org/uniprot/EDN1_HUMAN EDN1_HUMAN]] Endothelins are endothelium-derived vasoconstrictor peptides. | ||
<div style="background-color:#fffaf0;"> | |||
== Publication Abstract from PubMed == | |||
Endothelin, a 21-amino-acid peptide, participates in various physiological processes, such as regulation of vascular tone, humoral homeostasis, neural crest cell development and neurotransmission. Endothelin and its G-protein-coupled receptor are involved in the development of various diseases, such as pulmonary arterial hypertension, and thus are important therapeutic targets. Here we report crystal structures of human endothelin type B receptor in the ligand-free form and in complex with the endogenous agonist endothelin-1. The structures and mutation analysis reveal the mechanism for the isopeptide selectivity between endothelin-1 and -3. Transmembrane helices 1, 2, 6 and 7 move and envelop the entire endothelin peptide, in a virtually irreversible manner. The agonist-induced conformational changes are propagated to the receptor core and the cytoplasmic G-protein coupling interface, and probably induce conformational flexibility in TM6. A comparison with the M2 muscarinic receptor suggests a shared mechanism for signal transduction in class A G-protein-coupled receptors. | |||
Activation mechanism of endothelin ETB receptor by endothelin-1.,Shihoya W, Nishizawa T, Okuta A, Tani K, Dohmae N, Fujiyoshi Y, Nureki O, Doi T Nature. 2016 Sep 5;537(7620):363-368. doi: 10.1038/nature19319. PMID:27595334<ref>PMID:27595334</ref> | |||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |||
</div> | |||
<div class="pdbe-citations 5glh" style="background-color:#fffaf0;"></div> | |||
== References == | |||
<references/> | |||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Dohmae, N]] | |||
[[Category: Doi, T]] | |||
[[Category: Fujiyoshi, Y]] | [[Category: Fujiyoshi, Y]] | ||
[[Category: Nishizawa, T]] | [[Category: Nishizawa, T]] | ||
[[Category: Nureki, O]] | |||
[[Category: Okuta, A]] | [[Category: Okuta, A]] | ||
[[Category: Shihoya, W]] | [[Category: Shihoya, W]] | ||
[[Category: Tani, K]] | [[Category: Tani, K]] | ||
[[Category: Alpha helical]] | [[Category: Alpha helical]] | ||
[[Category: | [[Category: Signaling protein]] | ||
Revision as of 06:16, 21 September 2016
Human endothelin receptor type-B in complex with ET-1
| ||||||||||||